The inhalable version of CanSino’s Recombinant Covid-19 Vaccine (Adenovirus Type 5 Vector) has received clinical trial approval in Malaysia, says Solution Group Bhd (SGB).
KUALA LUMPUR, March 21 The Ministry of Health (MOH) has approved CanSino’s single-dose Convidecia Covid-19 vaccine to be used as a heterologous booster. The MOH, in a statement on its website today, said application for the CanSino-type booster dose would be available via MySejahtera soon. It.
© Provided by Xinhua It will be possible to fill and finish some 3 to 6 million doses of vaccines per month when production starts, with Malaysian phar
China-Malaysia vaccine cooperation strengthens regional vaccine supply macaubusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from macaubusiness.com Daily Mail and Mail on Sunday newspapers.
© Provided by Xinhua It will be possible to fill and finish some 3 to 6 million doses of vaccines per month when production starts, with Malaysian phar